Rigosertib (RIG) in combination with azacitidine (AZA) to modulate epigenetic effects and to overcome clinical resistance to hypomethylating agents (HMA) in myelodsyplastic syndrom... von Chaurasia, Pratima, Isoda, Fumiko, Novy, Tylar, Ross, Jamari, Odchimar-Reissig, Rosalie, Demakos, Erin P, Navada, Shyamala Chendal, Reddy, E. Premkumar, Silverman, Lewis R.

Volltext